Labetalol Hydrochloride
Product Images NDC 51662-1228

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 51662-1228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (1000320 0409 2267 20 Labetalol 20ml Multidose Vial 1)

This is a description of Labetalol Hydrochloride Injection medication manufactured by Hospira, Inc. The medication contains 100 mg of labetalol hydrochloride in 20 mL of injection solution. It is meant to be administered through intravenous injection only and should be protected from freezing and light. The medication comes in a 20 mL multi-dose vial and the carton should be retained until the time of use.*

FDA Label Image

Adverse Reactions Tabel (Adverse Reactions)

Labetalol is a medicine that comes in daily doses of 200, 300, 400, 600, 800, 900, 1200, and 1600 mg for patients. However, it appears that information about the number of patients taking each dose has been cut off. Labetalol may result in dizziness, fatigue, nausea, vomiting, dyspepsia, paresthesias, nasal stuffiness, ejaculation failure, impotence, and edema in varying percentages of patients depending on the dose administered.*

FDA Label Image

Carton (Carton)

This is a 20 mL multidose vial of Labetalol Hydrochloride Injection, USP with a strength of 100 mg/20 mL (5 mg/mL). It is for intravenous injection only and needs to be protected from freezing and light. The carton should be kept unopened until the time of use. The composition of this injection includes Labetalol hydrochloride, UsP, anhydrous dextrose, edetate disodium, citric acid monohydrate and sodium hydroxide, methylparaben and propylparaben. The recommended dosage and administration route for adults can be found in the package insert. The injection is to be stored at room temperature. The manufacturer is Hospira Inc. located in Lake Forest, IL6004S, USA.*

FDA Label Image

Dosage (Dosage)

This appears to be a medication dosing regimen chart. It lists different dosages based on the frequency of intake and the strength of the medication. The dosages range from 200mg to 2400mg.*

FDA Label Image

Hs Logo (How Supplied Logo)

FDA Label Image

Hs Tabel (How Supplied Tabel)

This is a description of the unit of sale and concentration of a medication. The medication is available in two concentrations of 100 mg/20 mL and 200 mg/40 mL. The carton contains one unit of the medication and the concentration of the medication in each unit is 5mg/mL. The medication is identified with two NDC codes: 0409-2267-20 and 0409-2267-54 respectively.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Label (Serialized 51662 1228 1 Labetalol HCl Injection 2)

FDA Label Image

Serialized Vial (Serialized Vial)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.